OrthoPediatrics Corp. (KIDS) Dividend History

OrthoPediatrics Corp. (KIDS) is a medical device company focused on providing specialized orthopedic solutions for children. It develops and markets innovative implants and surgical products aimed at treating pediatric orthopedic conditions, including limb deformities, fractures, and spinal disorders. The company emphasizes minimally invasive procedures and tailored treatments to improve outcomes for pediatric patients.

2850 Frontier Drive, Warsaw, IN, 46582
Phone: 574-268-6379
Website: https://www.orthopediatrics.com

Dividend History

OrthoPediatrics Corp. currently does not pay dividends

Company News

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

OrthoPediatrics Corp., a company focused on pediatric orthopedics, announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (POSNA) annual meeting as an Emerald Sponsor. The company highlighted its growing portfolio of pediatric-specific solutions, including OrthoPediatrics Specialty Bracing and Enabling Technologies.

GlobeNewswire Inc.
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance

OrthoPediatrics Corp. reported record preliminary unaudited revenue of $204.7 million in 2024, up 38% year-over-year. The company expects revenue to grow 15-18% in 2025 and adjusted EBITDA of $15-17 million.

GlobeNewswire Inc.
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors

Bruker Corporation announced the acquisition of Dynamic Biosensors GmbH, a company known for its development in biosensors. The acquisition is expected to strengthen Bruker's position in the pharma and biotech industries by leveraging its leading high-throughput Surface Plasmon Resonance portfolio and Dynamic Biosensors' unique instruments.

Benzinga

Featured Companies: AXGN BRKR TMDX
KIDS Stock Gains From Its New Enabling Technologies Division Launch

OrthoPediatrics Corp. (KIDS) has launched its Enabling Technologies division, which will leverage the company's core mission of addressing unmet pediatric needs in orthopedics. The new division is expected to differentiate KIDS' core business, generate sustainable revenue growth, and gain access to new markets and specialties beyond orthopedics.

Benzinga

Featured Companies: BSX ISRG TMDX
OrthoPediatrics (KIDS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

OrthoPediatrics reported Q2 2024 revenue of $52.8 million, up 33.5% year-over-year, and EPS of -$0.23 compared to -$0.19 a year ago. The company's performance across key product categories was mixed compared to analyst estimates.

Zacks Investment Research

Dividend data last updated 06/07/2025 22:19:45 UTC